Skip to content Skip to navigation

Medication Treatments

Methadone remains vital in buprenorphine era

October 20, 2016  |  Alison Knopf, Contributing Writer
Opioid treatment leaders see the two main medication treatments for opioid use disorders as complementary options.

Alkermes establishes grant program for nonprofits

September 16, 2016  |  Gary A. Enos, Editor
The maker of injectable naltrexone has announced an initiative in which nonprofit organizations may apply for funding to improve addiction and mental health systems of care.

Conference report: Presenter shows unbridled enthusiasm for methadone, buprenorphine

September 10, 2016  |  Gary A. Enos, Editor
A physician presenting at the Cape Cod Symposium on Addictive Disorders endorsed much wider access to both methadone and buprenorphine treatment for opioid dependence.

ASAM releases patient guide to opioid addiction treatment

September 2, 2016  |  Gary A. Enos, Editor
Assessment, treatment planning and medical interventions are addressed in the American Society of Addiction Medicine's (ASAM's) opioid treatment guide for patients and families.

Some doctors pursuing genetic clues to medication response or misuse

September 1, 2016  |  Gary A. Enos, Editor
Predictive testing to evaluate the potential risks and benefits of opioids and other medications appears to have wide applicability in many sectors of healthcare.

FDA mandates warnings, education on use of opioids with benzodiazepines

September 1, 2016  |  Gary A. Enos, Editor
Based partly on findings of increases in overdoses from concurrent prescribing of opioids and benzodiazepines, the Food and Drug Administration (FDA) is requiring boxed warnings and patient guides for nearly 400 individual drugs.

Treatment providers must respond to the market

August 23, 2016  |  Julie Miller, Editor in Chief
The addiction-treatment industry is most certainly at a crossroads, and leaders have an opportunity to shape the direction of the road ahead.

Clinicians must understand where sex, drugs and technology meet

August 19, 2016  |  Julie Miller, Editor in Chief
The “chemsex” culture is often characterized by intense experiences that combine crystal meth or similar drugs with risky sexual activity—all facilitated by GPS-based mobile apps.

MAT becoming an attractive deal target

August 18, 2016  |  Julie Miller, Editor in Chief
Margins for medication-assisted treatment providers are now matching or exceeding high-end residential programs, so the market can expect valuations to surge.

Government retains marijuana's Schedule I classification

August 11, 2016  |  Gary A. Enos, Editor
Today's announcement by the Drug Enforcement Administration (DEA) did include an indication that federally sanctioned marijuana research opportunities could expand.

Researchers to launch human testing of anti-cocaine vaccine

August 9, 2016  |  Gary A. Enos, Editor
Researchers at two New York institutions are recruiting active cocaine users for Phase I testing of an anti-cocaine vaccine that has shown promise in animal research.

Treatment behind the walls: States gather to share information

August 4, 2016  |  Alison Knopf, Contributing Writer
State correctional systems are gradually coming to realize that they can implement successful in-prison treatment programs with medication treatments at the center.


Subscribe to Medication Treatments